ArticleDigestive diseases and sciences2025

Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.

Jaakko Rautakorpi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.